Table 2:
Disease | Differentiating factors |
---|---|
Sjogren’s Syndrome | • Parotid gland involvement more common • Positive Anti-SSA (Ro) and/or -SSB (La) exclude IgG4-RD |
Sarcoidosis | • Cutaneous disease more common • ACE may be elevated, not expected in IgG4-RD • Splenomegaly can be seen but would be atypical in IgG4-RD • Granulomas exclude IgG4-RD |
ANCA-associated vasculitis (AAV, e.g. granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (EGPA)) | • Fever and very high CRP may be present and atypical for IgG4-RD • A positive MPO- or PR3-ANCA generally excludes IgG4-RD; only present in ~50% of EGPA cases • High-grade eosinophilia >3,000/mm3, as seen in EGPA, generally excludes IgG4-RD • Necrotizing vasculitis and/or granulomas exclude IgG4-RD |
Giant Cell Arteritis | • Fever and very high CRP may be present and atypical in IgG4-RD • Cranial symptoms (headache, scalp tenderness, jaw claudication, vision change) not typical in IgG4-RD |
Lymphoma | • Fever may be present • Malignant pathology excludes IgG4-RD • Rapid progression across tissue planes not seen in IgG4-RD |
Infection | • Fevers and very high CRP common, atypical in IgG4-RD • Rapid progression across tissue planes not seen in IgG4-RD |
Multicentric Castleman’s Disease (MCD) | • Fever and very high CRP often present and atypical in IgG4-RD • MCD pathology is distinct from IgG4-RD though both may have IgG4+ plasma cells infiltrating tissue |
Erdheim-Chester Disease | • Classic long-bone abnormalities (e.g., sclerosis) • Distinct pathology which includes foamy histiocytes excludes IgG4-RD • May have a BRAF mutation detectable in tissue and/or circulating blood |
Inflammatory Myofibroblastic Tumor | • Much more common in pediatric patients than adult patients • Distinct pathology reveals spindle cells • ALK (anaplastic lymphoma kinase), ROS-1, and other gene rearrangements detectable in ~50% of cases |